Drug Trial Radar · NCT02679456
Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Vulvovaginal Candidiasis
Last checked: Nov 20, 2026Latest source record: Jul 12, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
96
Actual
Start
Nov 2015
Primary completion
Aug 5, 2016
Study completion Aug 5, 2016
Sponsor
- Lead sponsor
- Scynexis, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- ethica Clinical Research Inc.
- First posted
- Feb 10, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (investigator)
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, multicenter, evaluator blinded study to evaluate the safety, tolerability, efficacy and pharmacokinetics of SCY-078 compared to Fluconazole in adult patients with moderate to severe Vulvovaginal Candidiasis (VVC) and a history of frequent episodes of VVC. Approximately 90 subjects, meeting the inclusion criteria will be enrolled and randomized in a 1:1:1 ratio to one of the 3 treatment arms: Oral SCY-078 in 2 dose regimens or oral Fluconazole. After enrollment, subjects will be evaluated on Day-5 (end of treatment visit), Day-24 (test of cure visit), Day-60, Day 90 and Day 120 (end of observation period visit) or at any time that a recurrence or clinical failure is suspected, up to the end of observation period.
Conditions
- Vulvovaginal Candidiasis
Interventions
SCY-078Drug
FluconazoleDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of subjects achieving therapeutic cure at the test of cure visit (Day 24 +/-3)Time frame: Day 24 +/- 3
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Hospital Dr. Francisco E. Moscoso Puello
Santo Domingo, Dominican Republic
Instituto Dermatologico y Cirugia de Piel
Santo Domingo, Dominican Republic
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.